Resultados de búsqueda

76 resultados.

Clinical trials of promising Cuban monoclonal antibody expanded

Registered in Cuba to treat head, neck, brain (in children and adults), esophageal and more recently, pancreatic tumors, with encouraging results, the humanized monoclonal antibody, nimotuzumab, is currently subject to 27 clinical trials to ensure its safety and effectiveness in the treatment of a further 11 types of cancer

Medical genetics program reduces infant mortality

Through the progressive implementation of the program throughout the country, the infant mortality rate due to congenital anomalies was reduced from 4.2 in 1980, to 0.9 per thousand live births

Life expectancy: 78.45 years

The provinces of Las Tunas and Holguín have a life expectancy of approximately 79.5 years, the highest in the country

The work of many hands

Created 50 years ago, the Cuban Institute of Meteorology is today a center of excellence in scientific research, providing specialized services that benefit various sectors of the country

On the path of innovation

Granma International interviews the director of Cuba’s pharmaceutical state enterprise group, BioCubaFarma, about the supply of medicine and investments underway

New brain mapping project

Cuba, China, and Canada will work together on a new brain mapping project

Irma’s rains help fill reservoirs

From September 5 to date, the volume of water in the country’s reservoirs has increased by 1.9 billion cubic meters

Promising research results

The discovery of the neuro-protective qualities of a new molecule called JM-20, opens up promising prospects for the treatment of cerebral ischemia

211 protected areas identified nationwide

By the end of 2015, a total of 211 protected areas had been identified in Cuba, 77 of which are of national importance given their natural ecosystems and cultural values